ARTL vs NRSN (Artelo Biosciences Inc. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Sep 29 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
Session Awaiting Data Feed
Market hours have concluded. Official daily closing logs are synchronizing (7:17 PM ET). Showing latest verified trading records.
NRSN leads by +5.92% Alpha Spread Today
ARTL is trading at -12.19% while NRSN is at -6.27% .
Started At
Official opening auction price
Last Recorded Trade Price
Recorded trade price at 7:17 PM ET
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | ARTL | NRSN | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | -12.19% | -6.27% | NRSN +5.92% |
| Net Dollar Move | $-0.63 | $-0.32 | NRSN higher move |
| Open Price | $4.89 | $5.04 | Gap: -5.42% vs -1.18% |
| Day High | $4.93 | $5.54 | Session peaks |
| Day Low | $4.43 | $4.36 | Session troughs |
| Intraday Spread | $0.50 | $1.18 | High/Low spread |
| Share Volume | 255.4K | 35.8K | ARTL more active |
| Est. Dollar Volume | $1.16M | $171.0K | ARTL higher liquidity |
Explore ARTL vs NRSN Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.